T1	Life-Stage-And-Gender 27 32	Males
T2	Life-Stage-And-Gender 37 44	females
T3	Eq-Comparison 45 55	≥ 18 years
T4	Eq-Operator 45 46	≥
T5	Eq-Value 47 49	18
T6	Eq-Temporal-Unit 50 55	years
T7	Age 59 62	age
T8	Observation 65 88	ECOG performance status
T9	Observation-Name 65 88	ECOG performance status
T10	Eq-Comparison 89 92	≤ 2
T11	Eq-Operator 89 90	≤
T12	Eq-Value 91 92	2
T13	Modifier 97 116	Histopathologically
T14	Procedure 120 133	cytologically
T15	Procedure-Name 120 133	cytologically
T16	Negation 144 147	non
T17	Modifier 150 158	squamous
T18	Modifier 162 170	squamous
T19	Condition 171 176	NSCLC
T20	Condition-Name 171 176	NSCLC
T21	Condition 181 200	Disease progression
T22	Procedure 217 226	treatment
T23	Eq-Comparison 232 242	one or two
T24	Eq-Value 232 235	one
T25	Eq-Value 239 242	two
T26	Procedure 243 260	treatment regimen
T27	Procedure 267 285	Treatment regimens
T28	Assertion 286 292	can be
T29	Procedure 293 305	chemotherapy
T30	Procedure-Name 293 305	chemotherapy
T31	Procedure 308 324	targeted therapy
T32	Procedure-Name 308 324	targeted therapy
T33	Procedure 327 345	biological therapy
T34	Procedure-Name 327 345	biological therapy
T35	Procedure 351 364	immunotherapy
T36	Procedure-Name 351 364	immunotherapy
T37	Modifier 380 390	Stage IIIB
T38	Eq-Unit 380 385	Stage
T39	Eq-Value 386 390	IIIB
T40	Modifier 396 406	metastatic
T41	Condition 407 414	disease
T42	Condition-Name 407 414	disease
T43	Eq-Comparison 417 425	Stage IV
T44	Eq-Unit 417 422	Stage
T45	Eq-Value 423 425	IV
T46	Condition 466 474	toxicity
T47	Drug 492 496	drug
T48	Negation 502 505	not
T49	Eq-Temporal-Recency 519 522	new
T50	Eq-Comparison 519 522	new
T51	Procedure 533 552	Maintenance therapy
T52	Procedure-Name 533 552	Maintenance therapy
T53	Procedure 563 592	platinum - based chemotherapy
T54	Procedure-Name 580 592	chemotherapy
T55	Negation 596 599	not
T56	Modifier 635 643	Adjuvant
T57	Modifier 647 658	neoadjuvant
T58	Procedure 659 671	chemotherapy
T59	Procedure-Name 659 671	chemotherapy
T60	Procedure 681 698	chemo - radiation
T61	Procedure-Name 681 698	chemo - radiation
T62	Modifier 703 714	early stage
T63	Condition 715 722	disease
T64	Negation 726 729	not
T65	Eq-Comparison 739 744	prior
T66	Eq-Temporal-Period 739 744	prior
T67	Procedure 745 761	systemic therapy
T68	Procedure-Name 754 761	therapy
T69	Eq-Comparison 764 769	Prior
T70	Eq-Temporal-Period 764 769	Prior
T71	Procedure 770 787	radiation therapy
T72	Procedure-Name 770 787	radiation therapy
T73	Negation 791 794	not
T74	Eq-Comparison 810 815	Prior
T75	Eq-Temporal-Period 810 815	Prior
T76	Procedure 816 829	immunotherapy
T77	Procedure-Name 816 829	immunotherapy
T78	Drug 837 864	PD - 1 / PD - L 1 inhibitor
T79	Drug-Name 837 864	PD - 1 / PD - L 1 inhibitor
T80	Negation 868 871	not
T81	Eq-Comparison 887 892	Prior
T82	Eq-Temporal-Period 887 892	Prior
T83	Procedure 893 902	treatment
T84	Modifier 907 915	advanced
T85	Modifier 919 929	metastatic
T86	Condition 930 937	disease
T87	Condition-Name 930 937	disease
T88	Procedure 988 997	Treatment
T89	Modifier 1001 1012	early stage
T90	Condition 1013 1020	disease
T91	Eq-Comparison 1023 1044	Stage IIIA or earlier
T92	Eq-Unit 1023 1028	Stage
T93	Eq-Value 1029 1033	IIIA
T94	Eq-Operator 1034 1044	or earlier
T95	Procedure 1054 1083	platinum - containing therapy
T96	Procedure-Name 1054 1083	platinum - containing therapy
T97	Negation 1089 1092	not
T98	Eq-Comparison 1119 1125	active
T99	Eq-Temporal-Period 1119 1125	active
T100	Modifier 1126 1131	brain
T101	Condition 1132 1142	metastasis
T102	Condition-Name 1132 1142	metastasis
T103	Modifier 1146 1172	leptomeningeal involvement
T104	Modifier 1178 1183	brain
T105	Observation 1184 1194	metastases
T106	Observation-Name 1184 1194	metastases
T107	Condition 1203 1215	asymptomatic
T108	Condition-Name 1203 1215	asymptomatic
T109	Observation 1228 1235	lesions
T110	Observation-Name 1228 1235	lesions
T111	Procedure 1239 1246	imaging
T112	Procedure-Name 1239 1246	imaging
T113	Eq-Comparison 1251 1259	at least
T114	Eq-Operator 1251 1259	at least
T115	Stability 1260 1266	stable
T116	Negation 1271 1278	without
T117	Observation 1306 1313	lesions
T118	Observation-Name 1306 1313	lesions
T119	Eq-Comparison 1318 1334	at least 4 weeks
T120	Eq-Operator 1318 1326	at least
T121	Eq-Value 1327 1328	4
T122	Eq-Temporal-Unit 1329 1334	weeks
T123	Assertion 1366 1373	require
T124	Eq-Temporal-Period 1374 1383	continued
T125	Eq-Comparison 1374 1383	continued
T126	Procedure 1384 1391	therapy
T127	Procedure-Name 1384 1391	therapy
T128	Drug 1397 1415	steroid medication
T129	Drug-Name 1397 1415	steroid medication
T130	Modifier 1441 1446	brain
T131	Observation 1447 1457	metastases
T132	Observation-Name 1447 1457	metastases
T133	Assertion 1462 1470	eligible
T134	Stability 1487 1493	stable
T135	Eq-Comparison 1498 1514	at least 4 weeks
T136	Eq-Operator 1498 1506	at least
T137	Eq-Value 1507 1508	4
T138	Eq-Temporal-Unit 1509 1514	weeks
T139	Study 1524 1537	randomization
T140	Eq-Comparison 1560 1572	at least one
T141	Eq-Operator 1560 1568	at least
T142	Eq-Value 1569 1572	one
T143	Modifier 1584 1588	lung
T144	Observation 1589 1595	lesion
T145	Observation-Name 1589 1595	lesion
T146	Eq-Comparison 1599 1606	≥ 10 mm
T147	Eq-Operator 1599 1600	≥
T148	Eq-Value 1601 1603	10
T149	Eq-Unit 1604 1606	mm
T150	Procedure 1610 1612	CT
T151	Procedure-Name 1610 1612	CT
T152	Procedure 1616 1619	MRI
T153	Procedure-Name 1616 1619	MRI
T154	Observation 1624 1630	RECIST
T155	Procedure 1646 1675	Radiographic tumor assessment
T156	Procedure-Name 1646 1675	Radiographic tumor assessment
T157	Eq-Comparison 1695 1709	within 28 days
T158	Eq-Operator 1695 1701	within
T159	Eq-Value 1702 1704	28
T160	Eq-Temporal-Unit 1705 1709	days
T161	Study 1719 1732	randomization
T162	Negation 1754 1757	non
T163	Modifier 1760 1768	squamous
T164	Condition 1769 1774	NSCLC
T165	Condition-Name 1769 1774	NSCLC
T166	Modifier 1801 1812	19 deletion
T167	Eq-Value 1801 1803	19
T168	Modifier 1817 1831	exon 21 L 858R
T169	Eq-Value 1822 1824	21
T170	Eq-Unit 1825 1826	L
T171	Condition 1832 1853	substitution mutation
T172	Condition-Name 1832 1853	substitution mutation
T173	Negation 1870 1877	without
T174	Condition 1878 1904	EGFR sensitizing mutations
T175	Condition-Name 1878 1904	EGFR sensitizing mutations
T176	Assertion 1909 1917	eligible
T177	Procedure 1953 1982	platinum - based chemotherapy
T178	Procedure-Name 1970 1982	chemotherapy
T179	Condition 2005 2025	ALK - rearrangements
T180	Condition-Name 2005 2025	ALK - rearrangements
T181	Assertion 2026 2035	should be
T182	Procedure 2036 2043	treated
T183	Drug 2064 2089	tyrosine kinase inhibitor
T184	Drug-Name 2064 2089	tyrosine kinase inhibitor
T185	Drug 2092 2095	TKI
T186	Drug-Name 2092 2095	TKI
T187	Study 2118 2123	study
T188	Assertion 2142 2147	would
T189	Procedure 2167 2176	treatment
T190	Condition-Name 2185 2199	adverse events
T191	Condition 2185 2199	adverse events
T192	Eq-Comparison 2207 2212	prior
T193	Eq-Temporal-Period 2207 2212	prior
T194	Procedure 2213 2229	systemic therapy
T195	Procedure-Name 2213 2229	systemic therapy
T196	Procedure 2232 2239	surgery
T197	Procedure-Name 2232 2239	surgery
T198	Procedure 2245 2257	radiotherapy
T199	Procedure-Name 2245 2257	radiotherapy
T200	Observation 2282 2287	CTCAE
T201	Procedure-Name 2282 2287	CTCAE
T202	Eq-Comparison 2292 2296	4.03
T203	Eq-Value 2292 2296	4.03
T204	Eq-Unit 2299 2304	Grade
T205	Eq-Comparison 2299 2304	Grade
T206	Eq-Comparison 2305 2308	≤ 2
T207	Eq-Operator 2305 2306	≤
T208	Eq-Value 2307 2308	2
T209	Exception 2311 2317	except
T210	Condition 2322 2349	neurological adverse events
T211	Condition-Name 2322 2349	neurological adverse events
T212	Assertion 2365 2376	resolved to
T213	Eq-Comparison 2383 2386	≤ 1
T214	Eq-Operator 2383 2384	≤
T215	Eq-Value 2385 2386	1
T216	Eq-Comparison 2455 2469	within 14 days
T217	Eq-Operator 2455 2461	within
T218	Eq-Value 2462 2464	14
T219	Eq-Temporal-Unit 2465 2469	days
T220	Eq-Comparison 2485 2490	1 Day
T221	Study 2493 2498	study
T222	Drug 2499 2503	drug
T223	Observation 2526 2536	Hemoglobin
T224	Observation-Name 2526 2536	Hemoglobin
T225	Eq-Comparison 2537 2547	≥ 9 g / dL
T226	Eq-Operator 2537 2538	≥
T227	Eq-Value 2539 2540	9
T228	Eq-Unit 2541 2542	g
T229	Eq-Unit 2545 2547	dL
T230	Procedure 2563 2574	transfusion
T231	Procedure 2585 2599	factor support
T232	Observation-Name 2585 2599	factor support
T233	Observation 2603 2628	Absolute neutrophil count
T234	Observation-Name 2603 2628	Absolute neutrophil count
T235	Eq-Comparison 2629 2644	≥ 1.5 x 109 / L
T236	Eq-Operator 2629 2630	≥
T237	Eq-Value 2631 2632	1
T238	Eq-Unit 2632 2634	.5
T239	Eq-Value 2637 2640	109
T240	Eq-Unit 2643 2644	L
T241	Observation-Name 2645 2681	independent of growth factor support
T242	Observation 2645 2681	independent of growth factor support
T243	Observation 2685 2699	Platelet count
T244	Observation-Name 2685 2699	Platelet count
T245	Eq-Comparison 2700 2715	≥ 100 x 109 / L
T246	Eq-Operator 2700 2701	≥
T247	Eq-Value 2702 2705	100
T248	Eq-Value 2708 2711	109
T249	Eq-Unit 2714 2715	L
T250	Procedure 2731 2742	transfusion
T251	Observation-Name 2746 2767	growth factor support
T252	Procedure 2753 2767	factor support
T253	Observation 2771 2792	Serum total bilirubin
T254	Observation-Name 2771 2792	Serum total bilirubin
T255	Eq-Comparison 2793 2798	≤ ULN
T256	Eq-Operator 2793 2794	≤
T257	Observation-Name 2795 2798	ULN
T258	Condition 2839 2856	Gilbert's disease
T259	Condition-Name 2839 2856	Gilbert's disease
T260	Observation 2871 2886	serum bilirubin
T261	Observation-Name 2871 2886	serum bilirubin
T262	Eq-Comparison 2887 2902	≤ 3.0 times ULN
T263	Eq-Operator 2887 2888	≤
T264	Eq-Value 2889 2890	3
T265	Eq-Unit 2890 2892	.0
T266	Eq-Unit 2899 2902	ULN
T267	Observation 2906 2909	AST
T268	Observation-Name 2906 2909	AST
T269	Observation 2914 2917	ALT
T270	Observation-Name 2914 2917	ALT
T271	Eq-Comparison 2918 2929	≤ 2.5 x ULN
T272	Eq-Operator 2918 2919	≤
T273	Eq-Value 2920 2921	2
T274	Eq-Unit 2921 2923	.5
T275	Eq-Unit 2926 2929	ULN
T276	Eq-Comparison 2932 2943	≤ 1.5 x ULN
T277	Eq-Operator 2932 2933	≤
T278	Eq-Value 2934 2937	1.5
T279	Eq-Unit 2940 2943	ULN
T280	Observation 2947 2967	alkaline phosphatase
T281	Observation-Name 2947 2967	alkaline phosphatase
T282	Eq-Comparison 2971 2982	> 2.5 x ULN
T283	Eq-Operator 2971 2972	>
T284	Eq-Value 2973 2974	2
T285	Eq-Unit 2974 2976	.5
T286	Eq-Unit 2979 2982	ULN
T287	Observation 2989 3005	Serum creatinine
T288	Observation-Name 2989 3005	Serum creatinine
T289	Eq-Comparison 3006 3017	≤ 1.5 x ULN
T290	Eq-Operator 3006 3007	≤
T291	Eq-Value 3008 3009	1
T292	Eq-Unit 3009 3011	.5
T293	Eq-Unit 3014 3017	ULN
T294	Observation 3021 3036	Life expectancy
T295	Observation-Name 3021 3036	Life expectancy
T296	Eq-Comparison 3037 3055	more than 12 weeks
T297	Eq-Operator 3037 3046	more than
T298	Eq-Value 3047 3049	12
T299	Eq-Temporal-Unit 3050 3055	weeks
T300	Life-Stage-And-Gender 3062 3068	Female
T301	Condition 3081 3103	childbearing potential
T302	Condition-Name 3081 3103	childbearing potential
T303	Polarity 3111 3119	negative
T304	Observation 3120 3134	pregnancy test
T305	Observation-Name 3120 3134	pregnancy test
T306	Study 3138 3146	baseline
T307	Life-Stage-And-Gender 3149 3156	Females
T308	Condition 3160 3182	childbearing potential
T309	Condition-Name 3160 3182	childbearing potential
T310	Condition 3198 3213	sexually mature
T311	Condition-Name 3198 3213	sexually mature
T312	Life-Stage-And-Gender 3214 3219	women
T313	Negation 3220 3227	without
T314	Eq-Comparison 3228 3233	prior
T315	Eq-Temporal-Period 3228 3233	prior
T316	Procedure 3234 3246	hysterectomy
T317	Procedure-Name 3234 3246	hysterectomy
T318	Condition 3279 3285	menses
T319	Condition-Name 3279 3285	menses
T320	Eq-Comparison 3293 3307	past 12 months
T321	Eq-Temporal-Period 3293 3297	past
T322	Eq-Value 3298 3300	12
T323	Eq-Temporal-Unit 3301 3307	months
T324	Life-Stage-And-Gender 3320 3325	women
T325	Procedure 3340 3351	amenorrheic
T326	Condition-Name 3340 3351	amenorrheic
T327	Eq-Comparison 3356 3373	12 or more months
T328	Eq-Value 3356 3358	12
T329	Eq-Operator 3359 3366	or more
T330	Eq-Temporal-Unit 3367 3373	months
T331	Condition 3404 3426	childbearing potential
T332	Condition-Name 3404 3426	childbearing potential
T333	Condition 3434 3444	amenorrhea
T334	Condition-Name 3434 3444	amenorrhea
T335	Assertion 3448 3456	possibly
T336	Eq-Comparison 3464 3469	prior
T337	Eq-Temporal-Period 3464 3469	prior
T338	Procedure 3470 3482	chemotherapy
T339	Procedure-Name 3470 3482	chemotherapy
T340	Drug 3485 3501	anti - estrogens
T341	Drug-Name 3485 3501	anti - estrogens
T342	Modifier 3507 3514	ovarian
T343	Condition-Name 3507 3526	ovarian suppression
T344	Condition 3515 3526	suppression
T345	Life-Stage-And-Gender 3534 3539	Women
T346	Condition 3543 3565	childbearing potential
T347	Condition-Name 3543 3565	childbearing potential
T348	Eq-Comparison 3568 3572	i .e
T349	Condition 3577 3589	menstruating
T350	Condition-Name 3577 3589	menstruating
T351	Life-Stage-And-Gender 3590 3595	women
T352	Polarity 3610 3618	negative
T353	Observation 3619 3639	urine pregnancy test
T354	Observation-Name 3619 3639	urine pregnancy test
T355	Polarity 3642 3650	positive
T356	Observation 3651 3662	urine tests
T357	Observation-Name 3651 3662	urine tests
T358	Observation 3686 3696	serum test
T359	Observation-Name 3686 3696	serum test
T360	Eq-Comparison 3710 3730	within the 24 - hour
T361	Eq-Operator 3710 3716	within
T362	Eq-Value 3721 3723	24
T363	Eq-Operator 3724 3725	-
T364	Eq-Temporal-Unit 3726 3730	hour
T365	Eq-Comparison 3751 3756	first
T366	Eq-Temporal-Recency 3751 3756	first
T367	Study 3765 3770	study
T368	Drug 3771 3775	drug
T369	Condition 3780 3788	Sexually
T370	Condition-Name 3780 3788	Sexually
T371	Eq-Comparison 3789 3795	active
T372	Eq-Temporal-Period 3789 3795	active
T373	Life-Stage-And-Gender 3796 3801	women
T374	Condition 3805 3827	childbearing potential
T375	Condition-Name 3805 3827	childbearing potential
T376	Study 3844 3849	study
T377	Assertion 3855 3863	agree to
T378	Procedure 3901 3914	contraception
T379	Procedure-Name 3901 3914	contraception
T380	Study 3940 3945	study
T381	Eq-Comparison 3954 3962	3 months
T382	Eq-Value 3954 3955	3
T383	Eq-Temporal-Unit 3956 3962	months
T384	Eq-Comparison 3975 3979	last
T385	Eq-Temporal-Recency 3975 3979	last
T386	Study 3988 3993	study
T387	Drug 3994 3998	drug
T388	Procedure 4011 4024	birth control
T389	Procedure-Name 4011 4024	birth control
T390	Procedure 4040 4059	intrauterine device
T391	Procedure-Name 4040 4059	intrauterine device
T392	Procedure 4062 4065	IUD
T393	Procedure-Name 4062 4065	IUD
T394	Procedure 4068 4091	plus one barrier method
T395	Stability 4102 4108	stable
T396	Procedure 4118 4140	hormonal contraception
T397	Procedure-Name 4118 4140	hormonal contraception
T398	Eq-Comparison 4145 4162	at least 3 months
T399	Eq-Operator 4145 4153	at least
T400	Eq-Value 4154 4155	3
T401	Eq-Temporal-Unit 4156 4162	months
T402	Modifier 4174 4178	oral
T403	Modifier 4181 4191	injectable
T404	Procedure 4194 4201	implant
T405	Drug 4204 4215	transdermal
T406	Modifier 4218 4226	plus one
T407	Procedure 4227 4241	barrier method
T408	Procedure 4249 4266	2 barrier methods
T409	Procedure-Name 4249 4266	2 barrier methods
T410	Procedure-Name 4269 4294	Effective barrier methods
T411	Procedure 4279 4294	barrier methods
T412	Modifier 4299 4303	male
T413	Life-Stage-And-Gender 4299 4303	male
T414	Life-Stage-And-Gender 4307 4313	female
T415	Drug 4314 4321	condoms
T416	Condition-Name 4314 4321	condoms
T417	Drug 4324 4334	diaphragms
T418	Drug-Name 4324 4334	diaphragms
T419	Drug 4341 4352	spermicides
T420	Drug-Name 4341 4352	spermicides
T421	Drug 4355 4361	creams
T422	Drug-Name 4355 4361	creams
T423	Drug 4365 4369	gels
T424	Drug-Name 4365 4369	gels
T425	Procedure 4385 4407	chemical to kill sperm
T426	Procedure-Name 4397 4407	kill sperm
T427	Life-Stage-And-Gender 4452 4456	male
T428	Condition 4474 4482	sexually
T429	Condition-Name 4474 4482	sexually
T430	Eq-Comparison 4483 4489	active
T431	Eq-Temporal-Period 4483 4489	active
T432	Condition 4514 4527	premenopausal
T433	Condition-Name 4514 4527	premenopausal
T434	Life-Stage-And-Gender 4528 4533	women
T435	Assertion 4536 4548	agreement to
T436	Eq-Value 4553 4556	two
T437	Eq-Comparison 4553 4556	two
T438	Procedure 4566 4579	contraception
T439	Procedure-Name 4566 4579	contraception
T440	Eq-Comparison 4596 4606	11 b above
T441	Eq-Value 4596 4598	11
T442	Procedure 4618 4627	treatment
T443	Eq-Comparison 4643 4660	at least 3 months
T444	Eq-Operator 4643 4651	at least
T445	Eq-Value 4652 4653	3
T446	Eq-Temporal-Unit 4654 4660	months
T447	Eq-Comparison 4671 4675	last
T448	Eq-Temporal-Recency 4671 4675	last
T449	Study 4684 4689	study
A1	Life-Stage-And-Gender-Type T1 male
A2	Life-Stage-And-Gender-Type T2 female
A3	Eq-Operator-Value T4 GTEQ
A4	Eq-Temporal-Unit-Value T6 year
A5	Observation-Type-Value E3 clinical-score
A6	Eq-Operator-Value T11 LTEQ
A7	Assertion-Type-Value E16 hypothetical
A8	Eq-Temporal-Recency-Value T49 first-time
A9	Eq-Temporal-Period-Value T66 past
A10	Eq-Temporal-Period-Value T70 past
A11	Eq-Temporal-Period-Value T75 past
A12	Eq-Temporal-Period-Value T82 past
A13	Eq-Operator-Value T94 GTEQ
A14	Eq-Temporal-Period-Value T99 present
A15	Eq-Operator-Value T114 GTEQ
A16	Stability-Value T115 stable
A17	Eq-Operator-Value T120 GTEQ
A18	Eq-Temporal-Unit-Value T122 week
A19	Assertion-Type-Value E72 hypothetical
A20	Eq-Temporal-Period-Value T124 present
A21	Assertion-Type-Value E78 hypothetical
A22	Stability-Value T134 stable
A23	Eq-Operator-Value T136 GTEQ
A24	Eq-Temporal-Unit-Value T138 week
A25	Eq-Operator-Value T141 GTEQ
A26	Eq-Operator-Value T147 GTEQ
A27	Eq-Operator-Value T158 LTEQ
A28	Eq-Temporal-Unit-Value T160 day
A29	Assertion-Type-Value E99 hypothetical
A30	Assertion-Type-Value E102 hypothetical
A31	Assertion-Type-Value E107 hypothetical
A32	Eq-Temporal-Period-Value T193 past
A33	Eq-Operator-Value T207 LTEQ
A34	Assertion-Type-Value E120 hypothetical
A35	Eq-Operator-Value T214 LTEQ
A36	Eq-Operator-Value T217 LTEQ
A37	Eq-Temporal-Unit-Value T219 day
A38	Observation-Type-Value E126 lab
A39	Eq-Operator-Value T226 GTEQ
A40	Observation-Type-Value E130 lab
A41	Eq-Operator-Value T236 GTEQ
A42	Observation-Type-Value E133 lab
A43	Eq-Operator-Value T246 GTEQ
A44	Observation-Type-Value E137 lab
A45	Eq-Operator-Value T256 LTEQ
A46	Observation-Type-Value E140 lab
A47	Eq-Operator-Value T263 LTEQ
A48	Observation-Type-Value E142 lab
A49	Observation-Type-Value E143 lab
A50	Eq-Operator-Value T272 LTEQ
A51	Eq-Operator-Value T277 LTEQ
A52	Observation-Type-Value E146 lab
A53	Eq-Operator-Value T283 GT
A54	Observation-Type-Value E148 lab
A55	Eq-Operator-Value T290 LTEQ
A56	Eq-Operator-Value T297 GT
A57	Eq-Temporal-Unit-Value T299 week
A58	Life-Stage-And-Gender-Type T300 female
A59	Polarity-Value T303 negative
A60	Observation-Type-Value E153 lab
A61	Life-Stage-And-Gender-Type T307 female
A62	Life-Stage-And-Gender-Type T312 female
A63	Eq-Temporal-Period-Value T315 past
A64	Eq-Temporal-Period-Value T321 past
A65	Eq-Temporal-Unit-Value T323 month
A66	Life-Stage-And-Gender-Type T324 female
A67	Eq-Operator-Value T329 GTEQ
A68	Eq-Temporal-Unit-Value T330 month
A69	Assertion-Type-Value E166 hypothetical
A70	Eq-Temporal-Period-Value T337 past
A71	Life-Stage-And-Gender-Type T345 female
A72	Life-Stage-And-Gender-Type T351 female
A73	Polarity-Value T352 negative
A74	Observation-Type-Value E175 lab
A75	Polarity-Value T355 positive
A76	Observation-Type-Value E176 lab
A77	Observation-Type-Value E177 lab
A78	Eq-Operator-Value T361 LTEQ
A79	Eq-Operator-Value T363 BETWEEN
A80	Eq-Temporal-Unit-Value T364 hour
A81	Eq-Temporal-Recency-Value T366 first-time
A82	Eq-Temporal-Period-Value T372 present
A83	Life-Stage-And-Gender-Type T373 female
A84	Assertion-Type-Value E186 hypothetical
A85	Eq-Temporal-Unit-Value T383 month
A86	Eq-Temporal-Recency-Value T385 most-recent-time
A87	Stability-Value T395 stable
A88	Eq-Operator-Value T399 GTEQ
A89	Eq-Temporal-Unit-Value T401 month
A90	Life-Stage-And-Gender-Type T413 male
A91	Life-Stage-And-Gender-Type T414 female
A92	Life-Stage-And-Gender-Type T427 male
A93	Eq-Temporal-Period-Value T431 present
A94	Life-Stage-And-Gender-Type T434 female
A95	Assertion-Type-Value E217 hypothetical
A96	Eq-Operator-Value T444 GTEQ
A97	Eq-Temporal-Unit-Value T446 month
A98	Eq-Temporal-Recency-Value T448 most-recent-time
R1	Or Arg1:T1 Arg2:T2
R2	Or Arg1:T13 Arg2:T14
R3	Found-By Arg1:T16 Arg2:T14
R4	Found-By Arg1:T19 Arg2:T14
R5	Or Arg1:T17 Arg2:T18
R6	Using Arg1:T22 Arg2:T26
R7	Using Arg1:T27 Arg2:T26
R8	Example-Of Arg1:T29 Arg2:T27
R9	Example-Of Arg1:T33 Arg2:T27
R10	Example-Of Arg1:T35 Arg2:T27
R11	Or Arg1:T29 Arg2:T31
R12	Or Arg1:T31 Arg2:T33
R13	Or Arg1:T33 Arg2:T35
R14	Treatment-For Arg1:T35 Arg2:T41
R15	Caused-By Arg1:T46 Arg2:T47
R16	Or Arg1:T56 Arg2:T57
R17	Or Arg1:T58 Arg2:T60
R18	Treatment-For Arg1:T58 Arg2:T63
R19	Treatment-For Arg1:T60 Arg2:T63
R20	Using Arg1:T76 Arg2:T78
R21	Treatment-For Arg1:T83 Arg2:T86
R22	Or Arg1:T84 Arg2:T85
R23	Treatment-For Arg1:T88 Arg2:T90
R24	And Arg1:T105 Arg2:T107
R25	And Arg1:T107 Arg2:T109
R26	Found-By Arg1:T109 Arg2:T111
R27	Using Arg1:T126 Arg2:T128
R28	Before Arg1:T135 Arg2:T139
R29	Found-By Arg1:T144 Arg2:T150
R30	Found-By Arg1:T144 Arg2:T152
R31	Or Arg1:T150 Arg2:T152
R32	Or Arg1:T152 Arg2:T154
R33	Before Arg1:T157 Arg2:T161
R34	Or Arg1:T166 Arg2:T168
R35	Treatment-For Arg1:T182 Arg2:T179
R36	Using Arg1:T182 Arg2:T183
R37	Abbrev-Of Arg1:T185 Arg2:T183
R38	Before Arg1:T185 Arg2:T187
R39	Caused-By Arg1:T191 Arg2:T194
R40	Caused-By Arg1:T191 Arg2:T198
R41	Caused-By Arg1:T191 Arg2:T200
R42	Or Arg1:T194 Arg2:T196
R43	Or Arg1:T196 Arg2:T198
R44	Before Arg1:T216 Arg2:T220
R45	Before Arg1:T216 Arg2:T221
R46	Before Arg1:T216 Arg2:T222
R47	Or Arg1:T230 Arg2:T231
R48	Or Arg1:T250 Arg2:T252
R49	If-Then Arg1:T260 Arg2:T258
R50	Or Arg1:T267 Arg2:T269
R51	Equivalent-To Arg1:T276 Arg2:T271
R52	And Arg1:T300 Arg2:T301
R53	And Arg1:T301 Arg2:T304
R54	During Arg1:T304 Arg2:T306
R55	And Arg1:T307 Arg2:T308
R56	Equivalent-To Arg1:T310 Arg2:T308
R57	If-Then Arg1:T312 Arg2:T310
R58	And Arg1:T324 Arg2:T325
R59	If-Then Arg1:T333 Arg2:T331
R60	Caused-By Arg1:T331 Arg2:T338
R61	Caused-By Arg1:T331 Arg2:T344
R62	Caused-By Arg1:T333 Arg2:T338
R63	Caused-By Arg1:T333 Arg2:T344
R64	Or Arg1:T338 Arg2:T340
R65	Or Arg1:T340 Arg2:T342
R66	Or Arg1:T340 Arg2:T344
R67	And Arg1:T345 Arg2:T346
R68	Example-Of Arg1:T349 Arg2:T346
R69	If-Then Arg1:T346 Arg2:T353
R70	If-Then Arg1:T351 Arg2:T349
R71	Equivalent-To Arg1:T356 Arg2:T353
R72	Before Arg1:T353 Arg2:T365
R73	Found-By Arg1:T356 Arg2:T358
R74	Before Arg1:T360 Arg2:T365
R75	And Arg1:T373 Arg2:T374
R76	During Arg1:T378 Arg2:T380
R77	After Arg1:T381 Arg2:T384
R78	Example-Of Arg1:T390 Arg2:T388
R79	Abbrev-Of Arg1:T392 Arg2:T390
R80	Example-Of Arg1:T404 Arg2:T396
R81	Or Arg1:T402 Arg2:T403
R82	Or Arg1:T403 Arg2:T404
R83	Or Arg1:T413 Arg2:T414
R84	Or Arg1:T415 Arg2:T417
R85	Or Arg1:T417 Arg2:T419
R86	Or Arg1:T421 Arg2:T423
R87	And Arg1:T427 Arg2:T428
R88	And Arg1:T428 Arg2:T432
R89	If-Then Arg1:T434 Arg2:T432
R90	If-Then Arg1:T434 Arg2:T435
R91	During Arg1:T438 Arg2:T442
R92	After Arg1:T443 Arg2:T447
E1	Eq-Comparison:T3
E2	Age:T7 Numeric-Filter:E1
E3	Observation:T8 Numeric-Filter:E4
E4	Eq-Comparison:T10
E5	Modifier:T13 Modifies:E10
E6	Procedure:T14
E7	Negation:T16 Negates:E8
E8	Modifier:T17 Modifies:E10
E9	Modifier:T18 Modifies:E10
E10	Condition:T19
E11	Condition:T21
E12	Procedure:T22
E13	Eq-Comparison:T23
E14	Procedure:T26 Minimum-Count:E13
E15	Procedure:T27
E16	Assertion:T28 Asserted:E17
E17	Procedure:T29
E18	Procedure:T31
E19	Procedure:T33
E20	Procedure:T35
E21	Modifier:T37
E22	Modifier:T40 Modifies:E23
E23	Condition:T41
E24	Eq-Comparison:T43
E25	Condition:T46
E26	Drug:T47
E27	Negation:T48
E28	Eq-Comparison:T50
E29	Procedure:T51
E30	Procedure:T53
E31	Negation:T55 Negates:E30
E32	Modifier:T56 Modifies:E34
E33	Modifier:T57 Modifies:E34
E34	Procedure:T58
E35	Procedure:T60
E36	Modifier:T62 Modifies:E35 Modifies:E37
E37	Condition:T63
E38	Negation:T64 Negates:E40
E39	Eq-Comparison:T65
E40	Procedure:T67 Temporality:E39
E41	Eq-Comparison:T69
E42	Procedure:T71 Temporality:E41
E43	Negation:T73 Negates:E42
E44	Eq-Comparison:T74
E45	Procedure:T76 Temporality:E44
E46	Drug:T78
E47	Negation:T80 Negates:E46
E48	Eq-Comparison:T81
E49	Procedure:T83 Temporality:E48
E50	Modifier:T84 Modifies:E49 Modifies:E52
E51	Modifier:T85 Modifies:E52
E52	Condition:T86
E53	Procedure:T88
E54	Modifier:T89 Modifies:E53 Modifies:E55
E55	Condition:T90 Stage:E56
E56	Eq-Comparison:T91
E57	Procedure:T95
E58	Negation:T97
E59	Eq-Comparison:T98
E60	Modifier:T100 Modifies:E61
E61	Condition:T101 Temporality:E59
E62	Modifier:T103 Modifies:E61 Modifies:E64
E63	Modifier:T104 Modifies:E64
E64	Observation:T105
E65	Condition:T107
E66	Observation:T109 Stability:T115
E67	Procedure:T111 Stability:T115
E68	Eq-Comparison:T113
E69	Negation:T116 Negates:E70
E70	Observation:T117 Duration:E71
E71	Eq-Comparison:T119
E72	Assertion:T123 Asserted:E74
E73	Eq-Comparison:T125
E74	Procedure:T126 Temporality:E73
E75	Drug:T128
E76	Modifier:T130 Modifies:E77
E77	Observation:T131
E78	Assertion:T133
E79	Eq-Comparison:T135
E80	Study:T139
E81	Eq-Comparison:T140
E82	Modifier:T143 Modifies:E83
E83	Observation:T144 Minimum-Count:E81 Numeric-Filter:E84
E84	Eq-Comparison:T146
E85	Procedure:T150
E86	Procedure:T152
E87	Observation:T154
E88	Procedure:T155 Temporality:E89
E89	Eq-Comparison:T157
E90	Study:T161
E91	Negation:T162 Negates:E92
E92	Modifier:T163 Modifies:E93
E93	Condition:T164
E94	Modifier:T166 Modifies:E96
E95	Modifier:T168 Modifies:E96
E96	Condition:T171
E97	Negation:T173 Negates:E98
E98	Condition:T174
E99	Assertion:T176 Asserted:E98
E100	Procedure:T177
E101	Condition:T179
E102	Assertion:T181 Asserted:E101 Asserted:E103
E103	Procedure:T182
E104	Drug:T183
E105	Drug:T185
E106	Study:T187
E107	Assertion:T188 Asserted:E108
E108	Procedure:T189
E109	Condition:T191 Temporality:E110
E110	Eq-Comparison:T192
E111	Procedure:T194 Temporality:E110
E112	Procedure:T196
E113	Procedure:T198
E114	Observation:T200 Numeric-Filter:E116
E115	Eq-Comparison:T202
E116	Eq-Comparison:T205
E117	Eq-Comparison:T206
E118	Exception:T209 From:E109 Except:E119
E119	Condition:T210
E120	Assertion:T212
E121	Eq-Comparison:T213
E122	Eq-Comparison:T216
E123	Eq-Comparison:T220
E124	Study:T221 Temporality:E123 Study-Of:E125
E125	Drug:T222
E126	Observation:T223 Numeric-Filter:E127
E127	Eq-Comparison:T225
E128	Procedure:T230
E129	Procedure:T231
E130	Observation:T233 Numeric-Filter:E131
E131	Eq-Comparison:T235
E132	Observation:T242
E133	Observation:T243 Numeric-Filter:E134
E134	Eq-Comparison:T245
E135	Procedure:T250
E136	Procedure:T252
E137	Observation:T253 Numeric-Filter:E138
E138	Eq-Comparison:T255
E139	Condition:T258
E140	Observation:T260 Numeric-Filter:E141
E141	Eq-Comparison:T262
E142	Observation:T267 Numeric-Filter:E144
E143	Observation:T269 Numeric-Filter:E144
E144	Eq-Comparison:T271
E145	Eq-Comparison:T276
E146	Observation:T280 Numeric-Filter:E147
E147	Eq-Comparison:T282
E148	Observation:T287 Numeric-Filter:E149
E149	Eq-Comparison:T289
E150	Observation:T294 Numeric-Filter:E151
E151	Eq-Comparison:T296
E152	Condition:T301 Polarity:T303
E153	Observation:T304 Polarity:T303
E154	Study:T306
E155	Condition:T308
E156	Condition:T310
E157	Negation:T313 Negates:E159
E158	Eq-Comparison:T314
E159	Procedure:T316 Temporality:E158
E160	Condition:T318 Temporality:E161
E161	Eq-Comparison:T320
E162	Procedure:T325
E163	Eq-Comparison:T327
E164	Condition:T331
E165	Condition:T333
E166	Assertion:T335 Asserted:E165
E167	Eq-Comparison:T336
E168	Procedure:T338 Temporality:E167
E169	Drug:T340
E170	Modifier:T342 Modifies:E171
E171	Condition:T344
E172	Condition:T346 Stage:E173 Polarity:T352
E173	Eq-Comparison:T348
E174	Condition:T349
E175	Observation:T353 Polarity:T352 Polarity:T355 Temporality:E178
E176	Observation:T356 Polarity:T355
E177	Observation:T358
E178	Eq-Comparison:T360
E179	Eq-Comparison:T365
E180	Study:T367 Study-Of:E181
E181	Drug:T368 Temporality:E179
E182	Condition:T369 Temporality:E183
E183	Eq-Comparison:T371
E184	Condition:T374
E185	Study:T376
E186	Assertion:T377
E187	Procedure:T378 Duration:E189
E188	Study:T380
E189	Eq-Comparison:T381
E190	Eq-Comparison:T384
E191	Study:T386 Temporality:E190 Study-Of:E192
E192	Drug:T387 Temporality:E190
E193	Procedure:T388
E194	Procedure:T390
E195	Procedure:T392
E196	Procedure:T394
E197	Procedure:T396 Stability:T395 Duration:E198
E198	Eq-Comparison:T398
E199	Modifier:T402 Modifies:E197
E200	Modifier:T403 Modifies:E197
E201	Procedure:T404
E202	Drug:T405
E203	Modifier:T406 Modifies:E197 Modifies:E204
E204	Procedure:T407
E205	Procedure:T408
E206	Procedure:T411
E207	Modifier:T412 Modifies:E206
E208	Drug:T415
E209	Drug:T417
E210	Drug:T419
E211	Drug:T421
E212	Drug:T423
E213	Procedure:T425
E214	Condition:T428 Temporality:E215
E215	Eq-Comparison:T430
E216	Condition:T432 Temporality:E215
E217	Assertion:T435 Asserted:E219
E218	Eq-Comparison:T437
E219	Procedure:T438 Minimum-Count:E218 Duration:E222
E220	Eq-Comparison:T440
E221	Procedure:T442
E222	Eq-Comparison:T443
E223	Eq-Comparison:T447
E224	Study:T449
